Back
Bioxytran Vs. Gossamer Bio Industry Stock Comparison
Sell
34
BIXT
Bioxytran
Last Price:
0.0900
Seasonality Move:
509.54%
Sell
31
GOSS
Gossamer Bio
Last Price:
0.70
Seasonality Move:
-10.7%
Sell
34
Bioxytran (BIXT)
is a Sell
Is Bioxytran a Buy, Sell or Hold?
- The current Bioxytran [BIXT] share price is $0.0987. The Score for BIXT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- BIXT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Gossamer Bio (GOSS)
is a Sell
Is Gossamer Bio a Buy, Sell or Hold?
- The current Gossamer Bio [GOSS] share price is $0.66. The Score for GOSS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- GOSS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIXT Stock Price Chart
GOSS Stock Price Chart
What is Gossamer Bio's stock price today?
-
The Gossamer Bio share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOSS is experiencing selling pressure, which indicates risk of future bearish movement.
BIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 51.77 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0868 - 0.1068) | Buy |
| Bollinger Bands (100): | (0.0896 - 0.1096) | Sell |
GOSS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 17.12 | Sell |
| Chaikin Money Flow: | -1027328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.77 - 0.93) | Sell |
| Bollinger Bands (100): | (0.83 - 1.05) | Sell |
BIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.1 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.1 | Sell |
| 200-day SMA: | 0.11 | Sell |
| 8-day EMA: | 0.1 | Buy |
| 20-day EMA: | 0.1 | Buy |
| 50-day EMA: | 0.1 | Buy |
| 200-day EMA: | 0.12 | Sell |
GOSS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.83 | Sell |
| 50-day SMA: | 0.92 | Sell |
| 200-day SMA: | 0.94 | Sell |
| 8-day EMA: | 0.74 | Sell |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 0.99 | Sell |
Bioxytran Earnings Growth & BIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Gossamer Bio Earnings Growth & GOSS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and a decrease next year of $0.42 per share.
Bioxytran Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gossamer Bio Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||